Marques, Tiago Reis http://orcid.org/0000-0003-0602-7661
Veronese, Mattia
Owen, David R.
Rabiner, Eugenii A.
Searle, Graham E.
Howes, Oliver D.
Funding for this research was provided by:
Medical Research Council (MC-A656-5QD30)
Brain and Behavior Research Foundation (094849/Z/10/Z)
Maudsley Charity (666)
Article History
Received: 24 August 2020
Accepted: 21 March 2021
First Online: 6 April 2021
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Dr. Reis Marques conducts research funded by the Medical Research Council (UK) and King’s College London. Dr. Reis Marques has received honoraria for speaking and chairing engagements from Lundbeck, Janssen, and Astellas. Dr. Veronese has received honoraria from GSK. Prof Howes conducts research funded by the Medical Research Council (UK), the National Institute of Health Research (UK), and the Maudsley Charity. Prof Howes has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organized by Astra-Zeneca, BMS, Eli Lilly, Jansenn, Lundbeck, Lyden-Delta, Servier, and Roche. Neither Prof Howes nor his family have been employed by or have holdings/a financial stake in any biomedical company. E.A.R. is a consultant for Opiant Pharmaceutical, AbbVie, and Teva, and a shareholder in GSK. GES and AS are employees of Invicro. Dr. Owen reports no financial relationships with commercial interests.